ÂÜÀòÂÒÂ×

Dr. Melissa Hurst, MSM, MBA, DBA, currently serves as the Director of Clinical Outsourcing and Vendor Management at Stoke Therapeutics since April 2024. Previously, Dr. Hurst held various leadership roles at Bellus Health, including Director of Clinical Outsourcing Vendor Management and Business Operations, where responsibilities included vendor evaluation and the design of outsourcing guidelines. Dr. Hurst also excelled at CSL Behring, first as a Senior Clinical Outsourcing Manager and later as Associate Director, managing outsourcing activities and enhancing the patient experience in clinical trials. Additional experience includes roles at AstraZeneca, Merck, and ICON Clinical Research, focusing on contract management, budget negotiations, and vendor relationships. Dr. Hurst holds a Doctor of Business Administration from Wilmington University and an MBA from Gwynedd Mercy University, among other qualifications.